AARTI DRUGS
Quarterly Results Analysis [Sep2025]
AARTI DRUGS Quarterly Results
| Consolidated | Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 Audited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹653 Cr | ₹591 Cr | ₹677 Cr | ₹557 Cr | ₹598 Cr | ₹555 Cr | ₹620 Cr | ₹606 Cr |
| Expenses | ₹569 Cr | ₹516 Cr | ₹583 Cr | ₹495 Cr | ₹531 Cr | ₹490 Cr | ₹534 Cr | ₹536 Cr |
| Operating Income | ₹84 Cr | ₹74 Cr | ₹93 Cr | ₹62 Cr | ₹67 Cr | ₹65 Cr | ₹86 Cr | ₹70 Cr |
| Other Income | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹12 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr |
| Interest | ₹8 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹8 Cr |
| Depreciation | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹14 Cr | ₹13 Cr |
| Profit Before Tax | ₹60 Cr | ₹51 Cr | ₹71 Cr | ₹51 Cr | ₹46 Cr | ₹44 Cr | ₹64 Cr | ₹52 Cr |
| Profit After Tax | ₹45 Cr | ₹54 Cr | ₹63 Cr | ₹37 Cr | ₹35 Cr | ₹33 Cr | ₹47 Cr | ₹37 Cr |
| EPS | ₹4.96 | ₹5.91 | ₹6.89 | ₹4.06 | ₹3.84 | ₹3.62 | ₹5.15 | ₹3.99 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| AARTI DRUGS | -5.1% | -13.2% | -5.6% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.7% | 4.3% | 0.2% |
| DIVIS LABORATORIES | -0.6% | -2.6% | 6.4% |
| CIPLA | -1.3% | -4.8% | 2.6% |
| TORRENT PHARMACEUTICALS | 0.4% | 4.7% | 19.8% |
| DR REDDYS LABORATORIES | -1.1% | -3.7% | 2.5% |
| MANKIND PHARMA | 0.9% | -7.8% | -13% |
| ZYDUS LIFESCIENCES | -0.3% | -7.8% | -1.9% |
| LUPIN | 0.9% | 5.8% | -2.2% |
AARTI DRUGS Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 10.55 % |
| Y-o-Y | 9.10 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Sep2025 | ₹653 Cr | 10.55 | |
| Jun2025 | ₹591 Cr | -12.74 | |
| Mar2025 | ₹677 Cr | 21.59 | |
| Dec2024 | ₹557 Cr | -6.97 | |
| Sep2024 | ₹598 Cr | 7.74 | |
| Jun2024 | ₹555 Cr | -10.43 | |
| Mar2024 | ₹620 Cr | 2.32 | |
| Dec2023 | ₹606 Cr | - | |
AARTI DRUGS Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 13.77 % |
| Y-o-Y | 25.70 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Sep2025 | ₹84 Cr | 13.77 | |
| Jun2025 | ₹74 Cr | -20.62 | |
| Mar2025 | ₹93 Cr | 51.17 | |
| Dec2024 | ₹62 Cr | -7.93 | |
| Sep2024 | ₹67 Cr | 3.22 | |
| Jun2024 | ₹65 Cr | -24.30 | |
| Mar2024 | ₹86 Cr | 22.34 | |
| Dec2023 | ₹70 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 2.87 % |
| Y-o-Y | 15.17 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Sep2025 | 12.91% | 2.87 | |
| Jun2025 | 12.55% | -8.99 | |
| Mar2025 | 13.79% | 24.35 | |
| Dec2024 | 11.09% | -1.07 | |
| Sep2024 | 11.21% | -4.19 | |
| Jun2024 | 11.7% | -15.46 | |
| Mar2024 | 13.84% | 19.52 | |
| Dec2023 | 11.58% | - | |
AARTI DRUGS Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -16.32 % |
| Y-o-Y | 29.18 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Sep2025 | ₹45 Cr | -16.32 | |
| Jun2025 | ₹54 Cr | -14.02 | |
| Mar2025 | ₹63 Cr | 69.24 | |
| Dec2024 | ₹37 Cr | 6.09 | |
| Sep2024 | ₹35 Cr | 5.08 | |
| Jun2024 | ₹33 Cr | -29.68 | |
| Mar2024 | ₹47 Cr | 28.87 | |
| Dec2023 | ₹37 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -24.29 % |
| Y-o-Y | 18.49 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Sep2025 | 6.92 % | -24.29 | |
| Jun2025 | 9.14 % | -1.51 | |
| Mar2025 | 9.28 % | 39.34 | |
| Dec2024 | 6.66 % | 14.04 | |
| Sep2024 | 5.84 % | -2.50 | |
| Jun2024 | 5.99 % | -21.49 | |
| Mar2024 | 7.63 % | 25.91 | |
| Dec2023 | 6.06 % | - | |
AARTI DRUGS Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -16.07 % |
| Y-o-Y | 29.17 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Sep2025 | ₹4.96 | -16.07 | |
| Jun2025 | ₹5.91 | -14.22 | |
| Mar2025 | ₹6.89 | 69.70 | |
| Dec2024 | ₹4.06 | 5.73 | |
| Sep2024 | ₹3.84 | 6.08 | |
| Jun2024 | ₹3.62 | -29.71 | |
| Mar2024 | ₹5.15 | 29.07 | |
| Dec2023 | ₹3.99 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD